Data
Medication Elimination
Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018. DOI: 10.1007/s13300-018-0373-9
A1c Reduction
Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018. DOI: 10.1007/s13300-018-0373-9
Weight Reduction
Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018. DOI: 10.1007/s13300-018-0373-9
Retention
![Bar chart comparing retention at one year: Virta (90%), Diabetes Medication Adherence (48%), Weight Loss Programs (13%)](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/63cec7b60a61a6f12c10fbc4_Virta%20-%20Retention%20at%20One%20Year.png)
Virta Health Registry for Remote Care of Chronic Conditions. Health and economic outcomes as of March 2019
Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307. Published 2016 Jul 22. doi:10.2147/PPA.S106821
Martin CK, Talamini L, Johnson A, Hymel AM, Khavjou O. Weight loss and retention in a commercial weight-loss program and the effect of corporate partnership. Int J Obes (Lond). 2010;34(4):742–750. doi:10.1038/ijo.2009.276
Rx Reduction
![Line chart showing Rx Reduction over 2 years](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/63cec7b60a61a6261c10fbbd_Virta%20-%20Rx%20Reduction.png)
Athinarayanan SJ, Adams RN, Hallberg SJ, et al. Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-year Non-randomized Clinical Trial. Frontiers in Endocrinology. 2019; 10:348. DOI: 10.3389/fendo.2019.00348
Type 2 Diabetes
![Bar charts showing comparison of Virta to Usual Care: Change in metabolic markers and medication use](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/6479210a7d7fa093f9729bd1_Research-T2DM.png)
Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.
Obesity
![Bar chart showing comparison of Virta to Usual Care: Weight loss](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/6479214ef2d870ce6bb56c6f_Research-Obesity.png)
Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.
Atherogenic Dyslipidemia
![Bar charts showing comparison of Virta to Usual Care: Atherogenic Dyslipidemia](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/64792155e7d96f5227096b79_Research-AthDys.png)
Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.
Hypertension
![Bar charts showing comparison of Virta to Usual Care: Hypertension](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/6479216aa166ff4d477247cb_Research-Hypertension.png)
Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.
Inflammation
![Bar charts showing comparison of Virta to Usual Care: Inflammation](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/64792173f6f3018afc51bd5f_Research-Inflammation.png)
Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.
Safety
![Bar charts showing comparison of Virta to Usual Care: Safety measures](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/6479217bc9feefab170c7b9b_Research-Safety.png)
Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.
Cardiovascular Risk Markers
![Bar charts showing comparison of Virta to Usual Care: Cardiovascular risk markers](https://cdn.prod.website-files.com/63b87f2b736a4604d643dbd4/6479218aa166ff4d4772498f_Research-CVD.png)
Hallberg SJ et al. Diabetes Therapy. 2018;9(2):583-612 and Bhanpuri NH et al. Cardiovasc Diabetol. 2018; 17:56.